| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |